Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
3 Reasons To Like This Small-Cap Biotech ETF: (SBIO)
FYI: Sector-focused ETFs can be high-risk, high-reward plays. ALPS Medical Breakthroughs (ARCA: SBIO) tanked 13% during the big August sell-off and has since re-bounded 6%. Broadly diversified peers saw smaller losses last month and are recovering nicely too. Regards, Ted http://license.icopyright.net/user/viewFreeUse.act?fuid=MjA0OTQwNjY=
